What is PTC Therapeutics's debt-to-equity?

PTC Therapeutics (PTCT) reported debt-to-equity of 372.3× in Q4 2021.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

PTC Therapeutics PTCT Debt-to-equity

Discontinued — last reported Q4 '21

Debt-to-equity at other companies

BioMarin PharmaceuticalsBMRN

0.2×+0.1×

ALN

Alnylam PharmaceuticalsALNY

0.2×-0.4×

Arrowhead ResearchARWR

0.2×0.0×

BiogenBIIB

0.4×+0.1×

Protagonist TherapeuticsPTGX

0×0.0×

Mirum Pharmaceuticals, Inc.MIRM

0.1×0.0×

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Current ratio2.4×-1.5×

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

total debt/total stockholders equity=372.3×

Based on the most recent quarter.

The official record: PTC Therapeutics’s 10-K, filed February 21, 2023, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's debt-to-equity?: PTC Therapeutics (PTCT) reported debt-to-equity of 372.3× in Q4 2021.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.